Haruhiko Imai

1.1k total citations
28 papers, 919 citations indexed

About

Haruhiko Imai is a scholar working on Molecular Biology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Haruhiko Imai has authored 28 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Epidemiology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Haruhiko Imai's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Haruhiko Imai is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Haruhiko Imai collaborates with scholars based in Japan, United States and Italy. Haruhiko Imai's co-authors include Eng M. Tan, Kendo Kiyosawa, Edward K. L. Chan, John C. Hamel, Yoshiyuki Nakano, Xiang‐Dong Fu, S Furuta, Robert Ochs, Rika Nakamura and Seiichi Furuta and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Gastroenterology.

In The Last Decade

Haruhiko Imai

27 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haruhiko Imai Japan 14 387 266 252 223 210 28 919
Bonnie J. Bordwell United States 9 212 0.5× 322 1.2× 187 0.7× 222 1.0× 17 0.1× 10 892
Yoshihiro Aiba Japan 16 173 0.4× 187 0.7× 49 0.2× 211 0.9× 184 0.9× 36 613
Roberta Benvenuto Italy 12 157 0.4× 252 0.9× 36 0.1× 344 1.5× 183 0.9× 24 776
S. D. Perova Russia 5 227 0.6× 146 0.5× 58 0.2× 78 0.3× 121 0.6× 8 728
K Rygaard Denmark 11 307 0.8× 135 0.5× 28 0.1× 161 0.7× 36 0.2× 14 735
Xiaochuan Xu United States 9 299 0.8× 124 0.5× 70 0.3× 107 0.5× 26 0.1× 14 1.1k
Katsumi Tsukazaki Japan 18 452 1.2× 326 1.2× 81 0.3× 174 0.8× 13 0.1× 65 1.1k
Lina Tan China 14 289 0.7× 71 0.3× 34 0.1× 181 0.8× 60 0.3× 31 650
Mihail Firan United States 9 282 0.7× 50 0.2× 315 1.3× 340 1.5× 24 0.1× 15 689
Masaaki Noguchi Japan 14 245 0.6× 145 0.5× 46 0.2× 163 0.7× 18 0.1× 85 866

Countries citing papers authored by Haruhiko Imai

Since Specialization
Citations

This map shows the geographic impact of Haruhiko Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruhiko Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruhiko Imai more than expected).

Fields of papers citing papers by Haruhiko Imai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruhiko Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruhiko Imai. The network helps show where Haruhiko Imai may publish in the future.

Co-authorship network of co-authors of Haruhiko Imai

This figure shows the co-authorship network connecting the top 25 collaborators of Haruhiko Imai. A scholar is included among the top collaborators of Haruhiko Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruhiko Imai. Haruhiko Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koziol, James A., Haruhiko Imai, Liping Dai, Jianying Zhang, & Eng M. Tan. (2018). Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens. Cancer Immunology Immunotherapy. 67(5). 835–841. 19 indexed citations
2.
Dai, Liping, et al.. (2014). Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma. Clinical Immunology. 152(1-2). 127–139. 47 indexed citations
3.
Takahashi, Yasuo, et al.. (1999). [Treatment of cancer ascites by combined intraperitoneal administration of low-dose CDDP and reinfusion of ultra-filtrated and concentrated ascitic fluid in patients].. PubMed. 26(12). 1820–4. 1 indexed citations
4.
Kobayashi, Masakazu, Akihiro Matsumoto, Kaname Yoshizawa, et al.. (1998). Clinical application of hepatitis C virus core protein in early diagnosis of acute hepatitis C. Journal of Gastroenterology. 33(4). 508–511. 9 indexed citations
5.
Matera, A. Gregory, Wei Wu, Haruhiko Imai, Christine L. O’Keefe, & Edward K. L. Chan. (1997). Molecular Cloning of the RNA Polymerase I Transcription Factor hUBF/NOR-90 (UBTF) Gene and Localization to 17q21.3 by Fluorescencein SituHybridization and Radiation Hybrid Mapping. Genomics. 41(1). 135–138. 8 indexed citations
6.
Shiojiri, Nobuyoshi, et al.. (1997). Mosaic pattern of ornithine transcarbamylase expression in spfash mouse liver.. PubMed. 151(2). 413–21. 13 indexed citations
7.
Kawa, Shigeyuki, Masuo Tokoo, Haruhiko Imai, et al.. (1996). Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines. Gastroenterology. 110(5). 1605–1613. 63 indexed citations
8.
Kobayashi, Masanori, Toshio Suzuki, Akihiko Urushihara, et al.. (1995). A case of alcoholic focal fatty liver with multiple nodules in the liver that improved in the follow-up period.. Kanzo. 36(9). 537–541. 1 indexed citations
9.
Imai, Haruhiko, et al.. (1995). Autoantibody to DNA topoisomerase II in primary liver cancer. PubMed. 1(4). 417–24. 19 indexed citations
10.
11.
Kiyosawa, K, Eiji Tanaka, T Sodeyama, et al.. (1994). Transmission of hepatitis C in an isolated area in Japan: Community-acquired infection. Gastroenterology. 106(6). 1596–1602. 130 indexed citations
12.
Imai, Haruhiko, Kendo Kiyosawa, Edward K. L. Chan, & Eng M. Tan. (1993). Autoantibodies in Viral Hepatitis-Related Hepatocellular Carcinoma. Intervirology. 35(1-4). 73–85. 22 indexed citations
13.
Imai, Haruhiko, Yoshiyuki Nakano, Kendo Kiyosawa, & Eng M. Tan. (1993). Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer. 71(1). 26–35. 66 indexed citations
14.
Imai, Haruhiko, Edward K. L. Chan, Kendo Kiyosawa, Xiang‐Dong Fu, & Eng M. Tan. (1993). Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma.. Journal of Clinical Investigation. 92(5). 2419–2426. 106 indexed citations
15.
Imai, Haruhiko, Robert Ochs, Kendo Kiyosawa, et al.. (1992). Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies.. PubMed. 140(4). 859–70. 108 indexed citations
16.
Chan, Edward K. L., Haruhiko Imai, John C. Hamel, & Eng M. Tan. (1991). Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor.. The Journal of Experimental Medicine. 174(5). 1239–1244. 133 indexed citations
17.
Oguchi, Hisao, Masuo Tokoo, Takeshi Kobayashi, et al.. (1990). A Comparative Study of the Clinical Usefulness of CA19-9-, CA50, Sialyl SSEA-1 and Dupan-2 for the Diagnosis of Pancreatic Cancer Used Alone or in Combination. Medical Entomology and Zoology. 19(4). 389–398. 4 indexed citations
18.
19.
Imai, Haruhiko, et al.. (1988). A case of cholangiocarcinoma detected after followup for seven years for thorotrast deposition. Gastroenterologia Japonica. 23(5). 570–575. 1 indexed citations
20.
Kiyosawa, Kendo, et al.. (1988). Serial assay for IGM anti‐HBc in patients with anti‐HBe‐positive chronic hepatitis and its significance for long‐term prognosis. Journal of Medical Virology. 24(3). 241–250. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bonnie J. Bordwell Breakdown of academic impact, for papers by Yoshihiro Aiba Breakdown of academic impact, for papers by Roberta Benvenuto Breakdown of academic impact, for papers by S. D. Perova Breakdown of academic impact, for papers by K Rygaard Breakdown of academic impact, for papers by Xiaochuan Xu Breakdown of academic impact, for papers by Katsumi Tsukazaki Breakdown of academic impact, for papers by Lina Tan Breakdown of academic impact, for papers by Mihail Firan Breakdown of academic impact, for papers by Masaaki Noguchi
Rankless by CCL
2026